Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.400
+0.120 (9.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
Apyx Medical Revenue
Apyx Medical had revenue of $11.49M in the quarter ending September 30, 2024, a decrease of -4.08%. This brings the company's revenue in the last twelve months to $48.54M, down -3.49% year-over-year. In the year 2023, Apyx Medical had annual revenue of $52.35M with 17.61% growth.
Revenue (ttm)
$48.54M
Revenue Growth
-3.49%
P/S Ratio
1.00
Revenue / Employee
$192,627
Employees
252
Market Cap
52.70M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 52.35M | 7.84M | 17.61% |
Dec 31, 2022 | 44.51M | -4.01M | -8.26% |
Dec 31, 2021 | 48.52M | 20.81M | 75.08% |
Dec 31, 2020 | 27.71M | -524.00K | -1.86% |
Dec 31, 2019 | 28.24M | 11.63M | 70.04% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
LakeShore Biopharma | 79.42M |
OptiNose | 75.67M |
BGM Group | 29.87M |
Rapid Micro Biosystems | 26.17M |
Kronos Bio | 9.87M |
Milestone Scientific | 8.88M |
vTv Therapeutics | 1.00M |
CollPlant Biotechnologies | 689.00K |
APYX News
- 8 days ago - Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference - GlobeNewsWire
- 12 days ago - Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering - GlobeNewsWire
- 13 days ago - Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook - GlobeNewsWire
- 27 days ago - Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024 - GlobeNewsWire
- 3 months ago - Renuvion Named #1 Trusted Body Contouring Technology by Doctors* - PRNewsWire
- 3 months ago - Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures - Business Wire